Overview of ADAPTIR Immunotherapeutics

ADAPTIR Immunotherapeutics

The ADAPTIR™ (modular protein technology) platform is Emergent BioSolutions’ novel platform technology for generating immunotherapies that have the potential to address unmet treatment needs in multiple clinical areas, including autoimmune and inflammatory diseases and oncology.

Modular Protein Design

Emergent BioSolutions' custom ADAPTIR platform is designed to expand the utility and effectiveness of antibodies in new arenas.


Subscribe to Emergent RSS